Which feature best distinguishes fentanyl from morphine in terms of clinical pharmacokinetics and receptor selectivity?

## Distinguishing Fentanyl from Morphine ### Potency and Pharmacokinetic Profile **Key Point:** Fentanyl is approximately **100 times more potent** than morphine at the mu opioid receptor. This dramatic potency difference, combined with its **lipophilic nature**, results in rapid CNS penetration and **rapid redistribution** to peripheral tissues, giving it a much shorter duration of action despite a long elimination half-life. **High-Yield:** This is the cardinal pharmacological distinction: fentanyl's high potency and short duration make it ideal for acute perioperative use and transdermal delivery, whereas morphine's longer duration suits chronic pain management. ### Pharmacokinetic Comparison | Parameter | Fentanyl | Morphine | |-----------|----------|----------| | **Potency (vs morphine)** | 100× | 1× (reference) | | **Lipophilicity** | Very high | Low | | **CNS penetration** | Rapid | Slower | | **Onset** | 1–2 min (IV) | 10–15 min (IV) | | **Duration (single dose)** | 30–60 min | 3–4 hours | | **Half-life** | 3–4 hours | 2–3 hours | | **Elimination** | Hepatic metabolism | Hepatic + renal (glucuronidation) | **Clinical Pearl:** Fentanyl's **context-sensitive half-time** (time to 50% reduction after infusion) increases with prolonged infusion due to peripheral saturation, making it unsuitable for long-term infusions without careful monitoring. Morphine's longer inherent duration makes it more predictable for chronic dosing. **Mnemonic:** **FLIP** = **F**entanyl is **L**ipophilic, **I**ncredibly potent, **P**erfect for short procedures. ### Mechanism of Potency Difference Fentanyl's 100-fold potency arises from: 1. Higher intrinsic activity at the mu receptor 2. Better CNS penetration due to lipophilicity 3. Optimal fit within the opioid receptor binding pocket ### Why Other Options Are Incorrect - **Option 1 (correct):** Fentanyl's 100× potency and short duration (via rapid redistribution) is the defining pharmacokinetic feature. - **Option 2:** Both fentanyl and morphine are mu-receptor agonists; fentanyl does not selectively bind delta receptors. - **Option 3:** Both undergo hepatic metabolism; morphine is also conjugated and excreted renally, but this is not the primary discriminator. - **Option 4:** At equianalgesic doses, respiratory depression is **equivalent**; potency differences do not confer safety advantages in respiratory effects.